Abstract:The synaptic vesicle glycoprotein 2C (SV2C) works in concert with the vesicular monoamine transporter 2 (VMAT2) to regulate vesicular dopamine dynamics. Because of the leaky nature of synaptic vesicles, substrate (e.g. FFN206, dopamine, MPP+) will leak out over time, decreasing the vesicular content. Blocking VMAT2 through inhibition results in an increase in the amount of substrate lost over time because of a loss of reuptake capabilities. A lack of SV2C expression similarly results in an increase in the amount of substrate lost over time. The cumulative loss of substrate over time is exacerbated in conditions with no SV2C expression and VMAT2 inhibition. Dopaminergic neurons of the substantia nigra exist in a persistent state of vulnerability resulting from high baseline oxidative stress, high‐energy demand, and broad unmyelinated axonal arborisations. Impairments in the storage of dopamine compound this stress because of cytosolic reactions that transform the vital neurotransmitter into an endogenous neurotoxicant, and this toxicity is thought to contribute to the dopamine neuron degeneration that occurs Parkinson's disease. We have previously identified synaptic vesicle glycoprotein 2C (SV2C) as a modifier of vesicular dopamine function, demonstrating that genetic ablation of SV2C in mice results in decreased dopamine content and evoked dopamine release in the striatum. Here, we adapted a previously published in vitro assay utilising false fluorescent neurotransmitter 206 (FFN206) to visualise how SV2C regulates vesicular dopamine dynamics and determined that SV2C promotes the uptake and retention of FFN206 within vesicles. In addition, we present data indicating that SV2C enhances the retention of dopamine in the vesicular compartment with radiolabelled dopamine in vesicles isolated from immortalised cells and from mouse brain. Further, we demonstrate that SV2C enhances the ability of vesicles to store the neurotoxicant 1‐methyl‐4‐phenylpyridinium (MPP+) and that genetic ablation of SV2C results in enhanced 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐induced vulnerability in mice. Together, these findings suggest that SV2C functions to enhance vesicular storage of dopamine and neurotoxicants and helps maintain the integrity of dopaminergic neurons.

VAMP2 chaperones α-synuclein in synaptic vesicle co-condensates

VAMP2 regulates phase separation of α-synuclein

VAMP2 regulates phase separation of alpha-synuclein

Functional cooperation of α-synuclein and VAMP2 in synaptic vesicle recycling

The Synaptic Vesicle Protein 2a Interacts with Key Pathogenic Factors in Alzheimer’s Disease: Implications for Treatment

The docking of synaptic vesicles on the presynaptic membrane induced by α-synuclein is modulated by lipid composition

Native α-synuclein induces clustering of synaptic-vesicle mimics via binding to phospholipids and synaptobrevin-2/VAMP2

Synaptic vesicle glycoprotein 2C (SV2C) modulates dopamine release and is disrupted in Parkinson disease

Single-vesicle Imaging Quantifies Calcium’s Regulation of Nanoscale Vesicle Clustering Mediated by Α-Synuclein

Membrane association of VAMP2 SNARE motif in cells and its regulation by different lipid phases of synaptic vesicle membrane

Synaptic vesicle glycoprotein 2C enhances vesicular storage of dopamine and counters dopaminergic toxicity

Different regions of synaptic vesicle membrane regulate VAMP2 conformation for the SNARE assembly

N-acetylation of α-synuclein enhances synaptic vesicle clustering mediated by α-synuclein and lysophosphatidylcholine

Synapsin 2a tetramerisation selectively controls the presynaptic nanoscale organisation of reserve synaptic vesicles

Altered Conformation of Α-Synuclein Drives Dysfunction of Synaptic Vesicles in a Synaptosomal Model of Parkinson's Disease.

CSPα reduces aggregates and rescues striatal dopamine release in α-synuclein transgenic mice

Α-Synuclein: A Multifunctional Player in Exocytosis, Endocytosis, and Vesicle Recycling

α-Synuclein at the Presynaptic Axon Terminal as a Double-Edged Sword

Synaptic vesicle 2C and its synaptic-related function.

Direct evidence for ultrastructures of the α-synuclein-associated synaptic vesicle pool in presynaptic terminals

Α-Synuclein Induces Deficiency in Clathrin-Mediated Endocytosis Through Inhibiting Synaptojanin1 Expression